MIR17HG, a breast cancer-related lncRNA, was shown to be considerably down-regulated in breast cancer tissues and cells in this study, and its low expression was linked to advanced TNM stage, tumor volume expansion, and survival rate. This evidence concerns the gene MIR17HG and neoplasm.